FREE Webinar for CAPRA MembersCannabis-Related Products:
Developing Therapeutics in an Evolving Legal/Regulatory Landscape
Developing Therapeutics in an Evolving Legal/Regulatory Landscape
The development and regulation of cannabis-related therapeutic products is a complex process given the wide range of unapproved products being marketed for numerous indications and the lack of harmony in the legal and regulatory frameworks employed across countries. The extensive marketing of unapproved products containing extracts or chemical constituents (e.g., cannabinoids) of cannabis complicates the growth of and innovation within commercial markets for the therapeutic use of these products. These complications have created a desperate need for a legal/regulatory framework that addresses unique issues that range from the protection of intellectual property to the safe use of products. Addressing these issues is important to ensure fair competition and growth within markets that support the use of safe and effective cannabis-related products. This webinar will consist of three major topics: First, a review the legal and regulatory landscape surrounding these products; Second, an examination of preclinical data to understand the adverse effects related to these products; and Third, a discussion on how these data can be leveraged to inform the development of a legal and regulatory framework that promotes a competitive market while ensuring the use of safe and effective cannabis-related products.
Dr. Sherry Boodram
CEO & Co-founder, CannDelta Inc.
CEO & Co-founder, CannDelta Inc.
Dr. Sherry Boodram is the CEO and Co-Founder of CannDelta Inc., a top regulatory and scientific cannabis consulting firm specializing in licensing and compliance across the US, Canada, and international markets. With extensive experience in cannabis regulations, Dr. Boodram has a unique background, including working within the Health Canada’s Cannabis and Controlled Substances Programs. She has overseen cannabis and controlled substances inspections and reviewed associated licensing applications, offering deep insights into regulatory compliance, licensing, and quality management systems within these regulated industries.
At CannDelta, Dr. Boodram has helped launch over 400 cannabis businesses, has supported governments in developing cannabis regulations and policies, and continues to provide strategic guidance to various firms including those aiming to expand internationally. She sits on various boards and holds a Ph.D. in Chemistry from York University and additional qualifications in Cannabis Law, Pharmaceutical Regulatory Affairs, and Quality Operations.
Dr. Marcus S. DelatteVP of Regulatory Strategy, Allucent
Dr. Marcus S. Delatte became a scientist given his interest in impacting public health. He earned a PhD at the LSU Health Sciences Center (2004) in Pharmacology and completed a post-doctoral fellowship at the Harvard Medical School/McLean Hospital (2008). As a trainee, he designed and conducted experiments to understand the effects of drugs such as cannabinoids on behavioral and physiological endpoints in animal species. Following his fellowship, Dr. Delatte joined the FDA as a Pharmacology/Toxicology Reviewer. He reviewed applications to conduct clinical studies and to acquire marketing approval for products such as cannabinoids. These experiences positioned him to enter the private sector, to rise to Vice President of Regulatory Strategy at Allucent (e.g., Contract Research Organization), and to continue advising domestic and international sponsors on product development strategies. Dr. Delatte continues to impact public health by teaching, advising companies, and mentoring scientists.
Jason Moscovici Lawyer, Provisions Legal Services
Jason Moscovici is a lawyer, biochemist, and founder of Provisions Legal Services, a Canadian law firm specialized in regulated industries. His practice focuses on intellectual property and regulatory compliance in fields such as cannabis, pharmaceuticals, medical devices, cosmetics, personal care products, nicotine delivery and natural health products. Jason’s focus on the valorization and enforcement of IP, as well as the numerous compliance issues that orbit regulated businesses, have allowed him to become one of the most trusted legal advisors to the emerging international cannabis industry. His perspectives on innovation, and the commercial hurdles related specifically to the area of controlled substances old and new, are routinely solicited by industry groups and other stakeholders in this space. He sits on several committees and working groups dedicated to identifying and establishing international legal practices in these areas.
Dr. Marcus S. Delatte,
Vice President of Regulatory Strategy, Allucent
Vice President of Regulatory Strategy, Allucent
ABOUT OUR GUEST
Dr. Marcus S. Delatte became a scientist given his interest in impacting public health. He earned a PhD at the LSU Health Sciences Center (2004) in Pharmacology and completed a post-doctoral fellowship at the Harvard Medical School/McLean Hospital (2008). As a trainee, he designed and conducted experiments to understand the effects of drugs such as cannabinoids on behavioral and physiological endpoints in animal species. Following his fellowship, Dr. Delatte joined the FDA as a Pharmacology/Toxicology Reviewer. He reviewed applications to conduct clinical studies and to acquire marketing approval for products such as cannabinoids. These experiences positioned him to enter the private sector, to rise to Vice President of Regulatory Strategy at Allucent (e.g., Contract Research Organization), and to continue advising domestic and international sponsors on product development strategies. Dr. Delatte continues to impact public health by teaching, advising companies, and mentoring scientists.
Jason Moscovici
Lawyer, Provisions Legal Services
Lawyer, Provisions Legal Services
ABOUT OUR GUEST
Jason Moscovici is a lawyer, biochemist, and founder of Provisions Legal Services, a Canadian law firm specialized in regulated industries. His practice focuses on intellectual property and regulatory compliance in fields such as cannabis, pharmaceuticals, medical devices, cosmetics, personal care products, nicotine delivery and natural health products. Jason’s focus on the valorization and enforcement of IP, as well as the numerous compliance issues that orbit regulated businesses, have allowed him to become one of the most trusted legal advisors to the emerging international cannabis industry. His perspectives on innovation, and the commercial hurdles related specifically to the area of controlled substances old and new, are routinely solicited by industry groups and other stakeholders in this space. He sits on several committees and working groups dedicated to identifying and establishing international legal practices in these areas.
Dr. Sherry Boodram
CEO & Co-founder, CannDelta Inc
ABOUT OUR GUEST
Dr. Sherry Boodram is the CEO and Co-Founder of CannDelta Inc., a top regulatory and scientific cannabis consulting firm specializing in licensing and compliance across the US, Canada, and international markets. With extensive experience in cannabis regulations, Dr. Boodram has a unique background, including working within the Health Canada’s Cannabis and Controlled Substances Programs. She has overseen cannabis and controlled substances inspections and reviewed associated licensing applications, offering deep insights into regulatory compliance, licensing, and quality management systems within these regulated industries.
At CannDelta, Dr. Boodram has helped launch over 400 cannabis businesses, has supported governments in developing cannabis regulations and policies, and continues to provide strategic guidance to various firms including those aiming to expand internationally. She sits on various boards and holds a Ph.D. in Chemistry from York University and additional qualifications in Cannabis Law, Pharmaceutical Regulatory Affairs, and Quality Operations.
Tuesday, July 29, 2025
Online
**Update: This webinar will be hosted using Go To Webinar.**
Event Registration Form: Please add your First name, Last name and the Email address you will use to log in on the day of the Webinar.
Registered attendees will receive an official Go To Webinar link to join the Webinar after the Registration deadline.
Check system requirements to avoid connection issues on the day of the event.
In case of unexpected interruptions, such as a power outage, please log back, and the Webinar will restart from where it was disconnected.
Presentation with Guest Speakers
1:00 pm - 2:00 pm EDT
Registration Closes
Friday, July 25, 2025 at 4:30 pm EDT
Member Rate -Free | Student Member Rate - Free | Non Member Rate - $80.00 | Non Member Student Rate - $25.00
(HST will be added at time of checkout)
Registration
| Non-Member | $80.00 + tax | |
| Non-Member (Student) | $25.00 + tax | |
| Proceed to Checkout | ||